(Reuters) – Moderna Inc’s COVID-19 vaccine could get emergency use authorization within 24 to 72 hours after U.S. Food and Drug Administration’s advisory committee meeting, Chief Executive Officer Stphane Bancel said on Wednesday.
The FDA will hold an advisory committee meet to discuss company’s request for emergency authorization for its COVID-19 vaccine on Dec. 17.
Speaking at an event conducted by Piper Sandler, Bancel said Moderna currently had millions of doses of vaccines that can be shipped as soon as its request is granted.
(Reporting by Mrinalika Roy and Trisha Roy in Bengaluru; Editing by Anil D’Silva)
